| # | Drug | Count |
|---|---|---|
| 0 | CAPLACIZUMAB | 4 |
| 1 | APADAMTASE ALFA | 1 |
| 2 | METHYLPREDNISOLONE | 1 |
| 3 | OBINUTUZUMAB | 1 |
| 4 | RAVULIZUMAB | 1 |
| 5 | RITUXIMAB | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | APADAMTASE ALFA | 1 | 0.0127 |
| 1 | CAPLACIZUMAB | 4 | 0.0022 |
| 2 | OBINUTUZUMAB | 1 | 0.0001 |
| 3 | METHYLPREDNISOLONE | 1 | 0.0000 |
| 4 | RITUXIMAB | 1 | 0.0000 |
| # | Drug class | Count |
|---|---|---|
| 0 | CD20-directed Cytolytic Antibody [EPC] | 1 |
| 1 | Corticosteroid [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD20-directed Cytolytic Antibody [EPC] | 1 | 0.0000 |
| 1 | Corticosteroid [EPC] | 1 | 0.0000 |